BG21857A3 - Метод за получаване на 1-субституирани пиразолони -(5) - Google Patents

Метод за получаване на 1-субституирани пиразолони -(5)

Info

Publication number
BG21857A3
BG21857A3 BG027977A BG2797774A BG21857A3 BG 21857 A3 BG21857 A3 BG 21857A3 BG 027977 A BG027977 A BG 027977A BG 2797774 A BG2797774 A BG 2797774A BG 21857 A3 BG21857 A3 BG 21857A3
Authority
BG
Bulgaria
Prior art keywords
obtaining
substituted pyrazolones
pyrazolones
substituted
Prior art date
Application number
BG027977A
Other languages
Bulgarian (bg)
English (en)
Inventor
Eike Moeller
Karl Meng
Egbert Wehinger
Harald Horstmann
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2319280A external-priority patent/DE2319280A1/de
Priority claimed from DE2363139A external-priority patent/DE2363139A1/de
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of BG21857A3 publication Critical patent/BG21857A3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • C07D231/20One oxygen atom attached in position 3 or 5
    • C07D231/22One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
    • C07D231/24One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms having sulfone or sulfonic acid radicals in the molecule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • C07D231/20One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/44Oxygen and nitrogen or sulfur and nitrogen atoms
    • C07D231/52Oxygen atom in position 3 and nitrogen atom in position 5, or vice versa

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Catalysts (AREA)
BG027977A 1973-04-17 1974-04-12 Метод за получаване на 1-субституирани пиразолони -(5) BG21857A3 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2319280A DE2319280A1 (de) 1973-04-17 1973-04-17 1-substituierte pyrazolone-(5), verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2363139A DE2363139A1 (de) 1973-12-19 1973-12-19 1-substituierte pyrazolone-(5), verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
BG21857A3 true BG21857A3 (bg) 1976-09-20

Family

ID=25764996

Family Applications (5)

Application Number Title Priority Date Filing Date
BG027980A BG21405A3 (bg) 1973-04-17 1974-04-12 Метод за получаване на 1-субституирани пиразолони-(5)
BG026395A BG21217A3 (bg) 1973-04-17 1974-04-12 Метод за получаване на 1-субституирани пиразолони-<5>
BG027979A BG22821A3 (bg) 1973-04-17 1974-04-12 Метод за получаване на 1-субституирани пиразолени -(5)
BG027977A BG21857A3 (bg) 1973-04-17 1974-04-12 Метод за получаване на 1-субституирани пиразолони -(5)
BG027978A BG21218A3 (bg) 1973-04-17 1974-04-12 Метод за получаване на 1-субституирани пиразолони -(5).

Family Applications Before (3)

Application Number Title Priority Date Filing Date
BG027980A BG21405A3 (bg) 1973-04-17 1974-04-12 Метод за получаване на 1-субституирани пиразолони-(5)
BG026395A BG21217A3 (bg) 1973-04-17 1974-04-12 Метод за получаване на 1-субституирани пиразолони-<5>
BG027979A BG22821A3 (bg) 1973-04-17 1974-04-12 Метод за получаване на 1-субституирани пиразолени -(5)

Family Applications After (1)

Application Number Title Priority Date Filing Date
BG027978A BG21218A3 (bg) 1973-04-17 1974-04-12 Метод за получаване на 1-субституирани пиразолони -(5).

Country Status (27)

Country Link
US (1) US3957814A (ko)
JP (1) JPS5314071B2 (ko)
AR (5) AR207444A1 (ko)
AT (1) AT337176B (ko)
BG (5) BG21405A3 (ko)
CA (1) CA1034953A (ko)
CH (5) CH603592A5 (ko)
DD (1) DD113757A5 (ko)
DK (1) DK136066C (ko)
EG (1) EG11157A (ko)
ES (3) ES425373A1 (ko)
FI (1) FI57587C (ko)
FR (1) FR2226172B1 (ko)
GB (1) GB1429141A (ko)
HK (1) HK70276A (ko)
HU (1) HU168590B (ko)
IE (1) IE39212B1 (ko)
IL (1) IL44626A (ko)
LU (1) LU69872A1 (ko)
NL (1) NL177917C (ko)
NO (1) NO138530C (ko)
PH (1) PH14829A (ko)
PL (1) PL96883B1 (ko)
RO (2) RO69740A (ko)
SE (1) SE408301B (ko)
SU (2) SU539525A3 (ko)
YU (1) YU104874A (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4056533A (en) * 1973-04-17 1977-11-01 Bayer Aktiengesellschaft Pyrazol-5-ones
DE2526467A1 (de) * 1975-06-13 1976-12-30 Bayer Ag 4-substituierte pyrazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3306366A1 (de) * 1983-02-24 1984-08-30 Bayer Ag, 5090 Leverkusen Muzolimin enthaltende arzneimittel, deren verwendung und verfahren zu deren herstellung
US4663327A (en) * 1984-05-23 1987-05-05 Bayer Aktiengesellschaft 1-heteroaryl-4-aryl-pyrazolin-5-ones
JPH0730031B2 (ja) * 1986-04-02 1995-04-05 日産化学工業株式会社 2―ピラゾリン―5―オン類の製造法
DE3738963A1 (de) * 1987-11-17 1989-05-24 Bayer Ag 3-aminopyrazolin-5-one
GB8912861D0 (en) * 1989-06-05 1989-07-26 Sherritt Gordon Ltd Purification of elemental sulphur
US5711929A (en) * 1989-05-06 1998-01-27 698638 Alberta Ltd. Purification of elemental sulphur
JPH079410Y2 (ja) * 1989-05-08 1995-03-06 株式会社アンレット 炭酸ガスレーザー光線発振器用ルーツブロワー
US5399565A (en) * 1990-07-17 1995-03-21 Eli Lilly And Company Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations therof
US5300514A (en) * 1990-07-17 1994-04-05 Eli Lilly And Company Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations thereof
ATE180475T1 (de) * 1990-09-21 1999-06-15 Rohm & Haas Dihydropyridazinone und pyridazinone als fungizide
CN1038249C (zh) * 1991-08-28 1998-05-06 罗姆和哈斯公司 含有二氢哒嗪酮及其相关化合物的杀菌组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2376380A (en) * 1945-05-22 Preparation of amino pyrazolones
GB636988A (en) * 1947-12-24 1950-05-10 Gevaert Photo Producten Naamlo Improvements in and relating to the production of colour photographic images
US2511231A (en) * 1949-03-26 1950-06-13 Eastman Kodak Co 1-cyanophenyl-3-acylamino-5-pyrazolone couplers for color photography
US2600788A (en) * 1949-06-07 1952-06-17 Eastman Kodak Co Halogen-substituted pyrazolone couplers for color photography
US2672417A (en) * 1949-12-31 1954-03-16 Gevaert Photo Prod Nv Production of color photographic images
NL121416C (ko) * 1961-05-31

Also Published As

Publication number Publication date
IE39212B1 (en) 1978-08-30
HK70276A (en) 1976-11-19
FR2226172B1 (ko) 1978-07-28
PH14829A (en) 1981-12-16
CH605800A5 (ko) 1978-10-13
DK136066B (da) 1977-08-08
FI57587C (fi) 1980-09-10
JPS5018466A (ko) 1975-02-26
NO741365L (no) 1974-10-18
AR205271A1 (es) 1976-04-21
FI57587B (fi) 1980-05-30
ES425373A1 (es) 1976-09-01
SU541430A3 (ru) 1976-12-30
ES447063A1 (es) 1977-06-16
AT337176B (de) 1977-06-10
IL44626A0 (en) 1974-06-30
IE39212L (en) 1974-10-17
CH596172A5 (ko) 1978-02-28
SU539525A3 (ru) 1976-12-15
GB1429141A (en) 1976-03-24
NL7405115A (ko) 1974-10-21
SE408301B (sv) 1979-06-05
NO138530B (no) 1978-05-12
BG21405A3 (bg) 1976-05-20
DD113757A5 (ko) 1975-06-20
LU69872A1 (ko) 1974-11-28
AR207444A1 (es) 1976-10-08
CA1034953A (en) 1978-07-18
AR208192A1 (es) 1976-12-09
BG21218A3 (bg) 1976-03-20
AR205272A1 (es) 1976-04-21
BG21217A3 (bg) 1976-03-20
RO69740A (ro) 1982-09-09
RO63749A (fr) 1979-01-15
DK136066C (da) 1978-01-16
JPS5314071B2 (ko) 1978-05-15
HU168590B (ko) 1976-06-28
NL177917C (nl) 1985-12-16
PL96883B1 (pl) 1978-01-31
BG22821A3 (bg) 1977-04-20
YU104874A (en) 1982-02-28
NO138530C (no) 1978-09-20
US3957814A (en) 1976-05-18
CH603592A5 (ko) 1978-08-31
CH605801A5 (ko) 1978-10-13
CH605797A5 (ko) 1978-10-13
ATA313274A (de) 1976-10-15
ES447064A1 (es) 1977-09-16
AR204951A1 (es) 1976-03-19
NL177917B (nl) 1985-07-16
FR2226172A1 (ko) 1974-11-15
IL44626A (en) 1980-01-31
EG11157A (en) 1978-03-29
AU6817474A (en) 1975-10-23

Similar Documents

Publication Publication Date Title
BG22827A3 (bg) Метод за получаване на 1,2,4-триазол-нуклеозиди
BG21208A3 (bg) Метод за получаване на 1- алилокси-2- хидрокси -3- алкинилами- нопропани
BG27079A3 (bg) Метод за получаване на 2,2,6,6-тетраметил-4-оксипиперидин
BG21857A3 (bg) Метод за получаване на 1-субституирани пиразолони -(5)
BG27080A3 (bg) Метод за получаване на 2,2,6,6-тетраметил-4- оксипиперидин
BG18872A3 (bg) Метод за получаване на 4-амино-1,2,4-триазин-5-они
BG20792A3 (bg) Метод за получаване на /2/ фурил - метил/ 6,7 бензоморфани
BG27081A3 (bg) Метод за получаване на 2,2,6,6-тетраметил-4- оксипиперидин
BG22394A3 (bg) Метод за получаване на пиразолони /5/
NL7410220A (nl) Werkwijze ter bereiding van n-gesubstitueerde 1-amino-3-fenoxypropanolen-(2).
BG25997A3 (bg) Метод за получаване на 7- ациламидо- 7- метоксицефалоспорини
BG20410A3 (bg) Метод за получаване на 3,4-дихидро-2н- изохинолин-1-они
BG25985A3 (bg) Метод за получаване на 13 бета-етил-17 d-етинил-гон- -4-еп-3-он-17 бета-ол
BG22404A3 (bg) Метод за получаване на а-аминоацил-3-халоцефалоспорини
NL7602646A (nl) 13.14-dehydro-11-deoxyprostaglandinen en werk- wijze ter bereiding ervan.
BG20583A3 (bg) Метод за получаване на 2,6-диамино-дихидропиридини
SU426992A1 (ko)
BG22381A3 (bg) Метод за получаване на диаминобензофенони
SU445670A1 (ru) Способ получени 10-оксо-4а-гидрокси10-фосфапергидроантрацена
SU458554A1 (ru) Способ получени 1-винилбензимидазола
SU457695A1 (ru) Способ получени -аминопропионитрила
BG22819A3 (bg) Метод за получаване на 3--амино-пиразолони-(5)
SU510468A1 (ru) Способ получени 4-амино-5-нитрофлуорантена
BG22823A3 (bg) Метод за получаване на нитромидазолови съединения
BG27092A3 (bg) Метод за получаване на n-фосфонометилглицинови триестери